investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Deciphering PI3K biology in health and disease

Investigator from Institut d'Investigació Biomédica de Bellvitge

0 Collaborator(s)

Funding source

European Commission (Belgium)

Related projects

Yves Pommier

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

Leukaemia

Iannis Aifantis

Genetic Dissection of Acute Myeloid Leukemia

Leukaemia

Pathology Hematology and hematologic malignancies

Elizaveta V Benevolenskaya

RBP2 Regulation Through Differential Recruitment to Genomic Loci

Leukaemia

Pathology Hematology and hematologic malignancies

Giovanna Tosato

Study of the Roles of SDF1 and CXCR4 in Hematopoiesis

Leukaemia

Hematology and hematologic malignancies

Rainer F Storb

Hematopoietic Chimerism after Stem Cell Allografts

Non-Hodgkin lymphoma Leukaemia

Hematology and hematologic malignancies Radiation Oncology

Charles Rabkin

BCL2 Translocations in Healthy Individuals

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Alex Kentsis

Aberrant activation of HGF/MET signaling as a therapeutic target in AML

Leukaemia

Annalisa Di Ruscio

Determining the Role of DNMT-interacting RNAs in Myeloid Disorders

Leukaemia

Hematology and hematologic malignancies Pathology

Dong-Er Zhang

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

Leukaemia

Hematology and hematologic malignancies Pathology